ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Price Down 10.2% – Here’s Why

ChronoScale Corporation Common Stock (NASDAQ:CHRN) dropped 10.2% during mid-day trading on Tuesday. The company traded as low as $10.38 and last traded at $10.44. Approximately 91,399 shares changed hands during trading, a decline of 59% from the average session volume of 221,147 shares. The stock had previously closed at $11.62.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on CHRN shares. Compass Point assumed coverage on shares of ChronoScale Corporation Common Stock in a research report on Friday, October 16th. They set a “buy” rating and a $25.00 target price for the company. Weiss Ratings cut shares of ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a research report on Friday, October 23rd. Finally, Northland Securities initiated coverage on ChronoScale Corporation Common Stock in a research note on Friday, September 18th. They set an “outperform” rating and a $32.00 price target for the company. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $21.00.

ChronoScale Corporation Common Stock Stock Performance

The company has a debt-to-equity ratio of 0.02, a current ratio of 0.30 and a quick ratio of 0.30. The company’s fifty day moving average price is $17.47 and its 200 day moving average price is $16.07. The company has a market cap of $1.54 billion, a PE ratio of -2.44 and a beta of 1.12.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last released its quarterly earnings results on Wednesday, October 14th. The company reported ($0.29) earnings per share for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 66.16% and a negative net margin of 135.66%. The firm had revenue of $41.48 million for the quarter. On average, equities research analysts predict that ChronoScale Corporation Common Stock will post -0.49 earnings per share for the current year.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.